Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Correction to: A consensus response on the complete picture: reply to Lynøe and Eriksson.

Choudhary AK, Narang SK, Moreno JA, Christian CW, Servaes S, Palusci VJ, Hedlund GL, Dias MS, Nelson MD, Silvera VM, Palasis S, Raissaki M, Rossi A, Offiah AC.

Pediatr Radiol. 2019 May;49(5):692-693. doi: 10.1007/s00247-019-04380-x.

PMID:
30877338
2.

A consensus response on the complete picture: reply to Lynøe and Eriksson.

Choudhary AK, Narang SK, Moreno JA, Christian CW, Servaes S, Palusci VJ, Hedlund GL, Dias MS, Nelson MD, Silvera VM, Palasis S, Raissaki M, Rossi A, Offiah AC.

Pediatr Radiol. 2019 Mar;49(3):424-428. doi: 10.1007/s00247-019-04341-4. Epub 2019 Feb 19. No abstract available. Erratum in: Pediatr Radiol. 2019 May;49(5):692-693.

PMID:
30783700
3.

Intracranial Calcifications in Young Children.

Dugan SL, Botto LD, Hedlund GL, Bale JF Jr.

Semin Pediatr Neurol. 2018 Jul;26:135-139. doi: 10.1016/j.spen.2017.03.022. Epub 2017 Apr 2.

PMID:
29961505
4.

Consensus statement on abusive head trauma in infants and young children.

Choudhary AK, Servaes S, Slovis TL, Palusci VJ, Hedlund GL, Narang SK, Moreno JA, Dias MS, Christian CW, Nelson MD Jr, Silvera VM, Palasis S, Raissaki M, Rossi A, Offiah AC.

Pediatr Radiol. 2018 Aug;48(8):1048-1065. doi: 10.1007/s00247-018-4149-1. Epub 2018 May 23. Review.

5.

The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders.

Stitt JM, Dzieciatkowska M, Edwards MG, Hansen K, Hedlund G, Dreskin SC.

Clin Exp Allergy. 2018 Jul;48(7):898-901. doi: 10.1111/cea.13149. Epub 2018 May 20. No abstract available.

PMID:
29671921
6.

T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.

Wingren AG, Parra E, Varga M, Kalland T, Sjogren HO, Hedlund G, Dohlsten M.

Crit Rev Immunol. 2017;37(2-6):463-481. doi: 10.1615/CritRevImmunol.v37.i2-6.130. Review.

PMID:
29773030
7.

Limitations of T2*-Gradient Recalled-Echo and Susceptibility-Weighted Imaging in Characterizing Chronic Subdural Hemorrhage in Infant Survivors of Abusive Head Trauma.

Cramer JA, Rassner UA, Hedlund GL.

AJNR Am J Neuroradiol. 2016 Sep;37(9):1752-6. doi: 10.3174/ajnr.A4769. Epub 2016 Mar 31.

8.

A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis.

Hawkins RE, Gore M, Shparyk Y, Bondar V, Gladkov O, Ganev T, Harza M, Polenkov S, Bondarenko I, Karlov P, Karyakin O, Khasanov R, Hedlund G, Forsberg G, Nordle Ö, Eisen T.

Clin Cancer Res. 2016 Jul 1;22(13):3172-81. doi: 10.1158/1078-0432.CCR-15-0580. Epub 2016 Feb 5.

9.

Recognition and Management of Acute Flaccid Myelitis in Children.

Nelson GR, Bonkowsky JL, Doll E, Green M, Hedlund GL, Moore KR, Bale JF Jr.

Pediatr Neurol. 2016 Feb;55:17-21. doi: 10.1016/j.pediatrneurol.2015.10.007. Epub 2015 Oct 20.

PMID:
26621554
10.

Parenchymal Brain Laceration as a Predictor of Abusive Head Trauma.

Palifka LA, Frasier LD, Metzger RR, Hedlund GL.

AJNR Am J Neuroradiol. 2016 Jan;37(1):163-8. doi: 10.3174/ajnr.A4519. Epub 2015 Oct 15.

12.

Common pediatric head and neck congenital/developmental anomalies.

LaPlante JK, Pierson NS, Hedlund GL.

Radiol Clin North Am. 2015 Jan;53(1):181-96. doi: 10.1016/j.rcl.2014.09.006. Review.

PMID:
25476180
13.

Musculoskeletal deformities following repair of large congenital diaphragmatic hernias.

Russell KW, Barnhart DC, Rollins MD, Hedlund G, Scaife ER.

J Pediatr Surg. 2014 Jun;49(6):886-9. doi: 10.1016/j.jpedsurg.2014.01.018. Epub 2014 Feb 5.

PMID:
24888828
14.

Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxin.

Eisen T, Hedlund G, Forsberg G, Hawkins R.

Curr Oncol Rep. 2014 Feb;16(2):370. doi: 10.1007/s11912-013-0370-0. Review.

15.

Congenital cytomegalovirus infection and brain clefting.

White AL, Hedlund GL, Bale JF Jr.

Pediatr Neurol. 2014 Mar;50(3):218-23. doi: 10.1016/j.pediatrneurol.2013.11.005. Epub 2013 Nov 16.

PMID:
24373410
16.

The tumor targeted superantigen ABR-217620 selectively engages TRBV7-9 and exploits TCR-pMHC affinity mimicry in mediating T cell cytotoxicity.

Hedlund G, Eriksson H, Sundstedt A, Forsberg G, Jakobsen BK, Pumphrey N, Rödström K, Lindkvist-Petersson K, Björk P.

PLoS One. 2013 Oct 23;8(10):e79082. doi: 10.1371/journal.pone.0079082. eCollection 2013.

17.

Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency.

Viau KS, Ernst SL, Pasquali M, Botto LD, Hedlund G, Longo N.

Mol Genet Metab. 2013 Nov;110(3):255-62. doi: 10.1016/j.ymgme.2013.08.020. Epub 2013 Sep 8.

PMID:
24071436
18.

Cerebral sinovenous thrombosis in pediatric practice.

Hedlund GL.

Pediatr Radiol. 2013 Jan;43(2):173-88. doi: 10.1007/s00247-012-2486-z. Epub 2012 Dec 1. Review.

PMID:
23212594
19.

Monotherapeutically nonactive CTLA-4 blockade results in greatly enhanced antitumor effects when combined with tumor-targeted superantigens in a B16 melanoma model.

Sundstedt A, Celander M, Eriksson H, Törngren M, Hedlund G.

J Immunother. 2012 May;35(4):344-53. doi: 10.1097/CJI.0b013e318253ec25.

PMID:
22495392
20.

Does intracranial venous thrombosis cause subdural hemorrhage in the pediatric population?

McLean LA, Frasier LD, Hedlund GL.

AJNR Am J Neuroradiol. 2012 Aug;33(7):1281-4. doi: 10.3174/ajnr.A2967. Epub 2012 Feb 16.

21.

Primary lesions of the root of the tongue.

Fang WS, Wiggins RH 3rd, Illner A, Hamilton BE, Hedlund GL, Hunt JP, Harnsberger HR.

Radiographics. 2011 Nov-Dec;31(7):1907-22. doi: 10.1148/rg.317095738.

PMID:
22084179
22.

Comments on hippocampal sclerosis in children younger than 2 years.

Hedlund GL.

Pediatr Radiol. 2011 Oct;41(10):1229-31. doi: 10.1007/s00247-011-2168-2. Epub 2011 Jul 22. No abstract available.

PMID:
21779893
23.

MPPH syndrome: two new cases.

Osterling WL, Boyer RS, Hedlund GL, Bale JF Jr.

Pediatr Neurol. 2011 May;44(5):370-3. doi: 10.1016/j.pediatrneurol.2010.12.009.

PMID:
21481746
24.

Naptumomab estafenatox, an engineered antibody-superantigen fusion protein with low toxicity and reduced antigenicity.

Forsberg G, Skartved NJ, Wallén-Ohman M, Nyhlén HC, Behm K, Hedlund G, Nederman T.

J Immunother. 2010 Jun;33(5):492-9. doi: 10.1097/CJI.0b013e3181d75820.

PMID:
20463598
25.

Neuroimaging of abusive head trauma.

Hedlund GL, Frasier LD.

Forensic Sci Med Pathol. 2009 Dec;5(4):280-90. doi: 10.1007/s12024-009-9132-6. Epub 2009 Dec 12. Review.

PMID:
20012715
26.

Cochlear abnormalities associated with enlarged vestibular aqueduct anomaly.

Atkin JS, Grimmer JF, Hedlund G, Park AH.

Int J Pediatr Otorhinolaryngol. 2009 Dec;73(12):1682-5. doi: 10.1016/j.ijporl.2009.08.028. Epub 2009 Sep 22.

PMID:
19775757
27.

Tumefactive intracranial presentation of precursor B-cell acute lymphoblastic leukemia.

Forester CM, Braunreiter CL, Yaish H, Hedlund GL, Afify Z.

Pediatr Radiol. 2009 Nov;39(11):1230-3. doi: 10.1007/s00247-009-1347-x. Epub 2009 Sep 10.

PMID:
19763560
28.

Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer.

Borghaei H, Alpaugh K, Hedlund G, Forsberg G, Langer C, Rogatko A, Hawkins R, Dueland S, Lassen U, Cohen RB.

J Clin Oncol. 2009 Sep 1;27(25):4116-23. doi: 10.1200/JCO.2008.20.2515. Epub 2009 Jul 27.

29.

Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.

Sundstedt A, Celander M, Ohman MW, Forsberg G, Hedlund G.

Int Immunopharmacol. 2009 Aug;9(9):1063-70. doi: 10.1016/j.intimp.2009.04.013. Epub 2009 May 3.

PMID:
19410661
30.

Pref-1 and adipokine expression in adipose tissues of GK and Zucker rats.

Barbu A, Hedlund GP, Lind J, Carlsson C.

Mol Cell Endocrinol. 2009 Feb 27;299(2):163-71. doi: 10.1016/j.mce.2008.11.019. Epub 2008 Nov 25.

PMID:
19084046
31.

Cerebellar leukoencephalopathy: most likely histiocytosis-related.

van der Knaap MS, Arts WF, Garbern JY, Hedlund G, Winkler F, Barbosa C, King MD, Bjørnstad A, Hussain N, Beyer MK, Gomez C, Patterson MC, Grattan-Smith P, Timmons M, van der Valk P.

Neurology. 2008 Oct 21;71(17):1361-7. doi: 10.1212/01.wnl.0000327680.74910.93.

PMID:
18936429
32.

Steroid treatment of hearing loss in enlarged vestibular aqueduct anomaly.

Grimmer JF, Hedlund G, Park A.

Int J Pediatr Otorhinolaryngol. 2008 Nov;72(11):1711-5. doi: 10.1016/j.ijporl.2008.08.009. Epub 2008 Sep 24.

PMID:
18817986
33.

Pilomyxoid astrocytoma: expanding the imaging spectrum.

Linscott LL, Osborn AG, Blaser S, Castillo M, Hewlett RH, Wieselthaler N, Chin SS, Krakenes J, Hedlund GL, Sutton CL.

AJNR Am J Neuroradiol. 2008 Nov;29(10):1861-6. doi: 10.3174/ajnr.A1233. Epub 2008 Aug 13.

34.

Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.

Sundstedt A, Celander M, Hedlund G.

Int Immunopharmacol. 2008 Mar;8(3):442-52. doi: 10.1016/j.intimp.2007.11.006. Epub 2007 Dec 7.

PMID:
18279798
35.

Progressive cerebral vascular degeneration with mitochondrial encephalopathy.

Longo N, Schrijver I, Vogel H, Pique LM, Cowan TM, Pasquali M, Steinberg GK, Hedlund GL, Ernst SL, Gallagher RC, Enns GM.

Am J Med Genet A. 2008 Feb 1;146A(3):361-7. doi: 10.1002/ajmg.a.31841.

PMID:
18203188
36.

Neuroimaging of herpesvirus infections in children.

Baskin HJ, Hedlund G.

Pediatr Radiol. 2007 Oct;37(10):949-63. Epub 2007 May 22. Review.

PMID:
17572889
37.

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma.

Shaw DM, Connolly NB, Patel PM, Kilany S, Hedlund G, Nordle O, Forsberg G, Zweit J, Stern PL, Hawkins RE.

Br J Cancer. 2007 Feb 26;96(4):567-74. Epub 2007 Feb 6.

38.

Vestibular symptoms in children with enlarged vestibular aqueduct anomaly.

Grimmer JF, Hedlund G.

Int J Pediatr Otorhinolaryngol. 2007 Feb;71(2):275-82. Epub 2006 Nov 17.

PMID:
17113162
39.

The role of diffusion-weighted magnetic resonance imaging in pediatric brain tumors.

Kan P, Liu JK, Hedlund G, Brockmeyer DL, Walker ML, Kestle JR.

Childs Nerv Syst. 2006 Nov;22(11):1435-9. Epub 2006 Sep 22. Review.

PMID:
17021722
40.

Non-enhancing pilocytic astrocytoma of the spinal cord.

Larson DB, Hedlund GL.

Pediatr Radiol. 2006 Dec;36(12):1312-5. Epub 2006 Oct 5.

PMID:
17021719
41.

Absent semicircular canals in CHARGE syndrome: radiologic spectrum of findings.

Morimoto AK, Wiggins RH 3rd, Hudgins PA, Hedlund GL, Hamilton B, Mukherji SK, Telian SA, Harnsberger HR.

AJNR Am J Neuroradiol. 2006 Sep;27(8):1663-71.

42.

Glutaric acidemia type 1.

Hedlund GL, Longo N, Pasquali M.

Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):86-94. Review.

43.

Introducing Phon: A Software Solution for the Study of Phonological Acquisition.

Rose Y, MacWhinney B, Byrne R, Hedlund G, Maddocks K, O'Brien P, Wareham T.

Proc Annu Boston Univ Conf Lang Dev. 2006 Apr;2006:489-500. No abstract available.

44.

Congenital frontonasal masses: developmental anatomy, malformations, and MR imaging.

Hedlund G.

Pediatr Radiol. 2006 Jul;36(7):647-62; quiz 726-7. Epub 2006 Mar 11. Review.

PMID:
16532348
45.

Chiari I malformation in patients with FG syndrome.

Gottfried ON, Hedlund GL, Opitz JM, Walker ML.

J Neurosurg. 2005 Aug;103(2 Suppl):148-55.

PMID:
16370281
46.

Sinogenic intracranial empyema in children.

Adame N, Hedlund G, Byington CL.

Pediatrics. 2005 Sep;116(3):e461-7.

PMID:
16140693
47.

Nitric oxide increases the signal intensity of the T1-weighted magnetic resonance image of blood.

Day RW, White KS, Hedlund GL.

J Cardiovasc Magn Reson. 2005;7(4):667-9.

PMID:
16136856
48.

Diffusion restriction of a spinal arachnoid cyst: case illustration.

Gottfried ON, Rao G, Anderson RC, Hedlund GL, Brockmeyer DL.

J Neurosurg. 2005 May;102(4 Suppl):439. No abstract available.

PMID:
15926400
49.

Clinicopathological review: tumefactive demyelination in a 12-year-old girl.

Anderson RC, Connolly ES Jr, Komotar RJ, Mack WJ, McKhann GM, Van Orman CB, Hedlund G, Proctor KA, Townsend JJ, Walker ML.

Neurosurgery. 2005 May;56(5):1051-7; discussion 1051-7. No abstract available.

PMID:
15854254
50.

Interleukin-10 mediates the protective effect of Linomide by reducing CXC chemokine production in endotoxin-induced liver injury.

Li X, Klintman D, Sato T, Hedlund G, Schramm R, Jeppsson B, Thorlacius H.

Br J Pharmacol. 2004 Dec;143(7):865-71. Epub 2004 Oct 18.

Supplemental Content

Loading ...
Support Center